Composition for preventing, inhibiting, or treating neuritis, containing peptide or protein including rgd motif

The present invention relates to a composition for preventing, inhibiting, or treating neuritis, containing a peptide or protein including the RGD motif and, specifically, to a pharmaceutical composition for preventing, inhibiting, or treating neuritis, containing: (a) a pharmaceutically effective amount of a peptide or a protein including the RGD motif; and (b) a pharmaceutically acceptable carrier. The present invention confirms a neuritis-relieving effect of saxatilin and analogs thereof, thereby allowing for the development of a therapeutic agent for stroke, having dual functions including a thrombolytic efficacy.